AS2717638

CAS No. 2148339-28-8

AS2717638( —— )

Catalog No. M26061 CAS No. 2148339-28-8

AS2717638 is an orally active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist (IC50: 38 nM for hLPA5).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 133 In Stock
5MG 121 In Stock
10MG 200 In Stock
25MG 400 In Stock
50MG 631 In Stock
100MG 995 In Stock
200MG 1349 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AS2717638
  • Note
    Research use only, not for human use.
  • Brief Description
    AS2717638 is an orally active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist (IC50: 38 nM for hLPA5).
  • Description
    AS2717638 is an orally active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist (IC50: 38 nM for hLPA5). It also significantly improves PGF2α-, PGE2-, and AMPA-induced allodynia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2148339-28-8
  • Formula Weight
    447.491
  • Molecular Formula
    C25H25N3O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 60 mg/mL (134.08 mM)
  • SMILES
    COc1cc2c(cn(-c3noc4ccc(C)cc34)c(=O)c2cc1OC)C(=O)N1CCCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Puerarin

    Puerarin (Kakonein), an isoflavones found in the root of Radix puerariae, is a 5-HT2C receptor and benzodiazepine site antagonist.

  • Caerulein, desulfate...

    Caerulein, desulfated is the desulfurated form of Caerulein. Caerulein is a deceptide with the same five carboxy-terminal amino acids as gastrin and cholecystatin (CCK).

  • Picumast

    Picumast shows antiallergic activity and can be utilized in the treatment of asthma. Picumast may be used in the treatment of therapeutic allergic airway diseases.